Bissoy.com
Doctors Medicines MCQs Q&A

3764 views

1 Answers

Desvenlafaxine, a serotonin and norepinephrine reuptake inhibitor (SNRI), is indicated for the treatment of major depressive disorder (MDD). The efficacy of Desvenlafaxine has been established in four short-term (8-week, placebo-controlled studies) and two maintenance studies in adult outpatients who met DSM-IV criteria for major depressive disorder.

Nevola 50 Tablet (Extended Release) সম্পর্কে বিস্তারিত জেনে নিন এই লিঙ্ক থেকে Nevola 50

3764 views

Related Questions